BDBM274 (3S)-3-[(6-{[3-(ethanesulfonyl)benzene]sulfonamidomethyl}pyridin-3-yl)formamido]-4-oxobutanoic acid::(S)-3-({6-[(3-Acetylsulfamoyl-benzenesulfonylamino)-methyl]pyridine-3-carbonyl}amino)-4-oxo-butyric AcidTrifluoroacetate::Inhibitor 55::Pyridine Scaffold 55
SMILES: CC(=O)NS(=O)(=O)c1cccc(c1)S(=O)(=O)NCc1ccc(cn1)C(=O)N[C@@H](CC(O)=O)C=O
InChI Key: InChIKey=WJYVXARRCUTRBW-HNNXBMFYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caspase-3 (Homo sapiens (Human)) | BDBM274 ((3S)-3-[(6-{[3-(ethanesulfonyl)benzene]sulfonamido...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Patents Similars | Article PubMed | 470 | -8.63 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sunesis Pharmaceuticals | Assay Description The effectiveness of compounds against the activity of human recombinant caspase-1-8 was measured using fluorometric assays. Assays were carried out ... | J Med Chem 45: 5005-22 (2002) Article DOI: 10.1021/jm020230j BindingDB Entry DOI: 10.7270/Q2B56GW5 | |||||||||||
More data for this Ligand-Target Pair |